Am J Epidemiol 2004; 159:1131-1139.
Copyright © 2004 by the Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Case-Control Study of Use of Nonsteroidal Antiinflammatory Drugs and Glioblastoma Multiforme
1 Division of Epidemiology and Biometrics, School of Public Health, College of Medicine and Public Health, Ohio State University, Columbus, OH.
2 Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
3 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.
Evidence from epidemiologic and experimental studies suggests that use of nonsteroidal antiinflammatory drugs (NSAIDs) reduces risk of colon and breast cancer. The association between use of aspirin and other NSAIDs and risk of adult glioblastoma multiforme (GBM) was evaluated among 236 incident GBM cases and 401 population-based controls frequency-matched on age, gender, and ethnicity from the San Francisco Bay Area Adult Glioma Study. Cases (or proxies) and controls were interviewed in person between May 1997 and August 2000. Cases with self-reported GBM reported less use of at least 600 pills of all types of NSAIDs combined during the 10-year prediagnostic period than did controls (odds ratio (OR) = 0.53, 95% confidence interval (CI): 0.3, 0.8). Findings were consistent for aspirin (OR = 0.51, 95% CI: 0.3, 0.8), ibuprofen (OR = 0.41, 95% CI: 0.2, 0.8), and naproxen/other NSAIDs (OR = 0.34, 95% CI: 0.1, 0.8). GBM cases also reported less use of acetaminophen than did controls (OR = 0.51, 95% CI: 0.3, 1.0). Eliminating participants who initiated NSAID use within 2 years of diagnosis yielded similar results. These findings show an inverse association between NSAID use and GBM. Further studies are warranted to determine whether NSAIDs might be effective in the inhibition of GBM development or progression.
acetaminophen; anti-inflammatory agents, non-steroidal; case-control studies; glioblastoma
Abbreviations: Abbreviations: CI, confidence interval; NSAID(s), nonsteroidal antiinflammatory drug(s); OR, odds ratio.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Schwartzbaum, K. Huang, S. Lawler, B. Ding, J. Yu, and E. A. Chiocca Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma Neuro Oncology, February 2, 2010; (2010): nop035v2 - nop035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Scheurer, R. El-Zein, P. A. Thompson, K. D. Aldape, V. A. Levin, M. R. Gilbert, J. S. Weinberg, and M. L. Bondy Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1277 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Schwartzbaum, A. Ahlbom, S. Lonn, B. Malmer, A. Wigertz, A. Auvinen, A. J. Brookes, H. Collatz Christensen, R. Henriksson, C. Johansen, et al. An International Case-Control Study of Interleukin-4R{alpha}, Interleukin-13, and Cyclooxygenase-2 Polymorphisms and Glioblastoma Risk Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2448 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Schwartzbaum, A. Ahlbom, B. Malmer, S. Lonn, A. J. Brookes, H. Doss, W. Debinski, R. Henriksson, and M. Feychting Polymorphisms Associated with Asthma Are Inversely Related to Glioblastoma Multiforme Cancer Res., July 15, 2005; 65(14): 6459 - 6465. [Abstract] [Full Text] [PDF]
|
|